Abstract:Factor-based induced reprogramming approaches have tremendous potential for human regenerative medicine, but the efficiencies of these approaches are still low. In this study, we analyzed the global transcriptional profiles of mouse induced pluripotent stem cells (miPSCs) and mouse embryonic stem cells (mESCs) from seven different labs and present here the first successful clustering according to cell type, not by lab of origin. We identified 2131 different expression genes (DEs) as candidate pluripotency-associated genes by comparing mESCs/miPSCs with somatic cells and 720 DEs between miPSCs and mESCs. Interestingly, there was a significant overlap between the two DE sets. Therefore, we defined the overlap DEs as “consensus DEs” including 313 miPSC-specific genes expressed at a higher level in miPSCs versus mESCs and 184 mESC-specific genes in total and reasoned that these may contribute to the differences in pluripotency between mESCs and miPSCs. A classification of “consensus DEs” according to their different expression levels between somatic cells and mESCs/miPSCs shows that 86% of the miPSC-specific genes are more highly expressed in somatic cells, while 73% of mESC-specific genes are highly expressed in mESCs/miPSCs, indicating that the miPSCs have not efficiently silenced the expression pattern of the somatic cells from which they are derived and failed to completely induce the genes with high expression levels in mESCs. We further revealed a strong correlation between oocyte-enriched factors and insufficiently induced mESC-specific genes and identified 11 hub genes via network analysis. In light of these findings, we postulated that these key hub genes might not only drive somatic cell nuclear transfer (SCNT) reprogramming but also augment the efficiency and quality of miPSC reprogramming.

Enhanced Generation of Human Induced Pluripotent Stem Cells by Ectopic Expression of Connexin 45

Connexin 43 is Involved in the Generation of Human-Induced Pluripotent Stem Cells.

Enhancement of Xrcc1-mediated Base Excision Repair Improves the Genetic Stability and Pluripotency of Ipscs

Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins.

Genome-wide gene expression analyses reveal unique cellular characteristics related to the amenability of HPC/HSCs into high-quality induced pluripotent stem cells

Improving the Reprogramming Efficiency of Somatic Cells to Induced Pluripotent Stem Cells.

Efficient Generation of Induced Pluripotent Stem Cells from Human Bone Marrow Mesenchymal Stem Cells

Knockdown H19 Accelerated iPSCs Reprogramming through Epigenetic Modifications and Mesenchymal-to-Epithelial Transition

Two Supporting Factors Greatly Improve the Efficiency of Human Ipsc Generation

Continuous Passages Accelerate the Reprogramming of Mouse Induced Pluripotent Stem Cells

High efficiency of reprogramming CD34⁺ cells derived from human amniotic fluid into induced pluripotent stem cells with Oct4.

Remodeling of Epigenetic Landscape During Induced Somatic Cell Reprogramming

EpEX/EpCAM and Oct4 or Klf4 Alone Are Sufficient to Generate Induced Pluripotent Stem Cells Through STAT3 and HIF2α

A murine ESC-like state facilitates transgenesis and homologous recombination in human pluripotent stem cells.

Cell Reprogramming‐Inspired Dynamically Responsive Hydrogel Boosts the Induction of Pluripotency via Phase‐Separated Biomolecular Condensates

A combined epigenetic and non-genetic approach for reprogramming human somatic cells

CRISPR-Based Chromatin Remodeling of the Endogenous Oct4 or Sox2 Locus Enables Reprogramming to Pluripotency.

High-Level Precise Knockin of Ipscs by Simultaneous Reprogramming and Genome Editing of Human Peripheral Blood Mononuclear Cells.

Mechanisms underlying the formation of induced pluripotent stem cells

Identifying Candidate Reprogramming Genes in Mouse Induced Pluripotent Stem Cells

Efficient Reprogramming of Human Cord Blood CD34+ Cells into Induced Pluripotent Stem Cells with OCT4 and SOX2 Alone.